Publications by authors named "Itay Shalev"

Claim this Profile
D
Deletion of Fibrinogen-like Protein 2 (FGL-2), a Novel CD4+ CD25+ Treg Effector Molecule, Leads to Improved Control of Echinococcus multilocularis Infection in Mice.
Junhua Wang, Dominique A Vuitton, Norbert Müller, Andrew Hemphill, Markus Spiliotis, Itay Shalev

PLoS Negl Trop Dis· May 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The regulatory T cell effector molecule fibrinogen-like protein 2 is necessary for the development of rapamycin-induced tolerance to fully MHC-mismatched murine cardiac allografts.
Peter Urbanellis, Wendy Shyu, Ramzi Khattar, Jihong Wang, Anna Zakharova, Itay Shalev

Immunology· January 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeted deletion of FGL2 leads to increased early viral replication and enhanced adaptive immunity in a murine model of acute viral hepatitis caused by LCMV WE.
Ramzi Khattar, Olga Luft, Nataliya Yavorska, Itay Shalev, M James Phillips

PLoS One· July 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Protein interferon-stimulated gene 15 conjugation delays but does not overcome coronavirus proliferation in a model of fulminant hepatitis.
Xue-Zhong Ma, Agata Bartczak, Jianhua Zhang, Wei He, Itay Shalev

J Virol· June 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterization of fibrinogen-like protein 2 (FGL2): monomeric FGL2 has enhanced immunosuppressive activity in comparison to oligomeric FGL2.
Hao Liu, Peter S Yang, Tina Zhu, Justin Manuel, Jianhua Zhang, Itay Shalev

Int J Biochem Cell Biol· February 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Role of regulatory T cells in the promotion of transplant tolerance.
Itay Shalev, Nazia Selzner, Wendy Shyu, David Grant, Gary Levy

Liver Transpl· July 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of a novel biomarker gene set with sensitivity and specificity for distinguishing between allograft rejection and tolerance.
Lin Xie, Naotsugu Ichimaru, Miwa Morita, Jiajie Chen, Ping Zhu, Itay Shalev

Liver Transpl· April 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
FGL2/fibroleukin mediates hepatic reperfusion injury by induction of sinusoidal endothelial cell and hepatocyte apoptosis in mice.
Nazia Selzner, Hao Liu, Markus U Boehnert, Oyedele A Adeyi, Itay Shalev

J Hepatol· January 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Making sense of regulatory T cell suppressive function.
Itay Shalev, Moritz Schmelzle, Simon C Robson, Gary Levy

Semin Immunol· August 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The immunosuppressive pipeline: meeting unmet needs in liver transplantation.
Nazia Selzner, David R Grant, Itay Shalev, Gary A Levy

Liver Transpl· December 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The novel immunoregulatory molecule FGL2: a potential biomarker for severity of chronic hepatitis C virus infection.
Katharina Foerster, Ahmed Helmy, Yi Zhu, Ramzi Khattar, Oyedele A Adeyi, Itay Shalev

J Hepatol· October 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genetic determinants of mouse hepatitis virus strain 1 pneumovirulence.
Julian L Leibowitz, Rajiv Srinivasa, Shawn T Williamson, Ming Ming Chua, Mingfeng Liu, Itay Shalev

J Virol· September 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Role of FGL2 in the Pathogenesis and Treatment of Hepatitis C Virus Infection.
Itay Shalev, Nazia Selzner, Ahmed Helmy, Katharina Foerster, Oyedele A Adeyi

Rambam Maimonides Med J· July 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The novel CD4+CD25+ regulatory T cell effector molecule fibrinogen-like protein 2 contributes to the outcome of murine fulminant viral hepatitis.
Itay Shalev, Kit Man Wong, Katharina Foerster, Yi Zhu, Cecilia Chan

Hepatology· February 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The FGL2-FcgammaRIIB pathway: a novel mechanism leading to immunosuppression.
Hao Liu, Itay Shalev, Justin Manuel, Wei He, Elisa Leung

Eur J Immunol· November 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeted deletion of fgl2 leads to impaired regulatory T cell activity and development of autoimmune glomerulonephritis.
Itay Shalev, Hao Liu, Cheryl Koscik, Agata Bartczak, Mojib Javadi

J Immunol· January 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Murine hepatitis virus strain 1 as a model for severe acute respiratory distress syndrome (SARS).
Nadine DeAlbuquerque, Ehtesham Baig, Max Xuezhong, Itay Shalev, M James Phillips

Adv Exp Med Biol· December 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Murine hepatitis virus strain 1 produces a clinically relevant model of severe acute respiratory syndrome in A/J mice.
Nadine De Albuquerque, Ehtesham Baig, Xuezhong Ma, Jianhua Zhang, William He, Itay Shalev

J Virol· November 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cytokine-induced hepatic apoptosis is dependent on FGL2/fibroleukin: the role of Sp1/Sp3 and STAT1/PU.1 composite cis elements.
Mingfeng Liu, Michael Mendicino, Qin Ning, Anand Ghanekar, Wei He, Itay Shalev

J Immunol· June 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeted deletion of Fgl-2/fibroleukin in the donor modulates immunologic response and acute vascular rejection in cardiac xenografts.
Michael Mendicino, MingFeng Liu, Anand Ghanekar, Wei He, Cheryl Koscik, Itay Shalev

Circulation· July 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis